About Immunodeficiency with severe reduction in serum IgG and IgA with normal/elevated IgM and normal number of B-cells
Immunodeficiency with severe reduction in serum IgG and IgA with normal/elevated IgM and normal number of B-cells is a rare disease catalogued by Orphanet (ORPHA:331240). Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries worldwide.
Clinical Trial Eligibility Tips
What to know before applying to Immunodeficiency with severe reduction in serum IgG and IgA with normal/elevated IgM and normal number of B-cells trials.
Search ClinicalTrials.gov for "Immunodeficiency with severe reduction in serum IgG and IgA with normal/elevated IgM and normal number of B-cells" or Orphanet code ORPHA:331240 to find disease-specific recruiting studies.
Ask your specialist to refer you to an Orphanet-accredited Centre of Expertise for this condition.
Natural history studies and patient registries often open enrolment before drug trials — contact the Orphanet patient community first.
Patient Resources
Find recruiting Immunodeficiency with severe reduction in serum IgG and IgA with normal/elevated IgM and normal number of B-cells trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Immunodeficiency with severe reduction in serum IgG and IgA with normal/elevated IgM and normal number of B-cells. Updated daily.